Analyst Rating Update on Monsanto Company (MON)

Monsanto Company (MON) : Zacks Investment Research ranks Monsanto Company (MON) as 4, which is a Sell recommendation. 7 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 5 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 12 research analysts is 1.83, which indicates as a Buy.

Monsanto Company (MON) : The consensus price target for Monsanto Company (MON) is $108.1 for the short term with a standard deviation of $14.77. The most optimist securities analyst among the 10 who monitor the stock believes that the stock can reach $132, however, the pessimist price target for the company is $88.

Company shares have received an average consensus rating of Hold for the current week Also, In a research note released to the investors, Citigroup maintains its rating on Monsanto Company (NYSE:MON).The analysts at the brokerage house have a current rating of Neutral on the shares. In a recent information released to the investors, Citigroup raises the new price target from $94 per share to $112 per share. The rating by the firm was issued on July 1, 2016.


Monsanto Company (NYSE:MON): The stock opened at $105.54 on Wednesday but the bulls could not build on the opening and the stock topped out at $106.41 for the day. The stock traded down to $104.17 during the day, due to lack of any buying support eventually closed down at $104.36 with a loss of -1.19% for the day. The stock had closed at $105.62 on the previous day. The total traded volume was 3,607,216 shares.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Companys seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, it produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment, it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.